abs51.txt	background		crohn's	disease	(cd)	is	highly	heterogeneous		due	in	large	part	tovariability	in	cellular	processes	that	underlie	the	natural	history	of	cd	thereby	confounding	effective	therapy		there	is	a	critical	need	to	advanceunderstanding	of	the	cellular	mechanisms	that	drive	cd	heterogeneity	methods		we	performed	small	rna	sequencing	of	adult	colon	tissue	from	cd	and	nibdcontrols		colonic	epithelial	cells	and	immune	cells	were	isolated	from	colonictissues		and	microrna-31	(mir-31)	expression	was	measured		mir-31	expression	wasmeasured	in	colonoid	cultures	generated	from	controls	and	patients	with	cd		weperformed	small	rna-sequencing	of	formalin-fixed	paraffin-embedded	colon	andileum	biopsies	from	treatment-naive	pediatric	patients	with	cd	and	controls	andcollected	data	on	disease	features	and	outcomes	results		small	rna-sequencing	and	microrna	profiling	in	the	colon	revealed	2distinct	molecular	subtypes		each	with	different	clinical	associations		notably	we	found	that	mir-31	expression	was	a	driver	of	these	2	subtypes	and		further	that	mir-31	expression	was	particularly	pronounced	in	epithelial	cells		colonoidsrevealed	that	mir-31	expression	differences	are	preserved	in	this	ex	vivo	system	in	adult	patients		low	colonic	mir-31	expression	levels	at	the	time	of	surgerywere	associated	with	worse	disease	outcome	as	measured	by	need	for	an	endileostomy	and	recurrence	of	disease	in	the	neoterminal	ileum		in	pediatricpatients		lower	mir-31	expression	at	the	time	of	diagnosis	was	associated	withfuture	development	of	fibrostenotic	ileal	cd	requiring	surgeryconclusions		thesefindings	represent	an	important	step	forward	in	designing	more	effective	clinicaltrials	and	developing	personalized	cd	therapies	funding		this	work	was	supported	by	ccf	career	development	award	(szs)	r01-es024983	from	niehs	(szs	and	tsf)		1r01dk104828-01a1	from	niddk	(szs	andtsf)		p01-dk094779-01a1	from	niddk	(szs)		p30-dk034987	from	niddk	(szs)	1-16-ace-47	ada	pathway	award	(ps)		unc	nutrition	obesity	research	center	pilot	&feasibility	grant	p30dk056350	(ps)		ccf	pro-kiids	network	(szs	and	ps)		unc	cgibdt32	training	grant	from	niddk	(jbb)		t32	training	grant	(5t32gm007092-42)	fromnigms	(mh)		and	share	from	the	helmsley	trust	(szs)		the	unc	translationalpathology	laboratory	is	supported		in	part		by	grants	from	the	national	cancerinstitute	(3p30ca016086)	and	the	unc	university	cancer	research	fund	(ucrf)	(ps)	
